96 related articles for article (PubMed ID: 35170)
1. [Studies on the biotransformation of reproterol. Structure determination of the main metabolite (author's transl)].
Niebch G; Klingler KH; Eikelmann G; Kucharczyk N
Arzneimittelforschung; 1978; 28(5):765-7. PubMed ID: 35170
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation of reproterol in the intestinal tract of the rat.
Kucharczyk N; Yang JT; Sofia RD
Arzneimittelforschung; 1981; 31(12):2085-8. PubMed ID: 7199302
[TBL] [Abstract][Full Text] [Related]
3. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].
Niebch G; Obermeier K; Vergin H; Thiemer K
Arzneimittelforschung; 1977; 27(12):37-45. PubMed ID: 576829
[TBL] [Abstract][Full Text] [Related]
4. [Compound with bronchospasmolytical activity from the chemical class of beta-phenylethyl-aminoalkyl-xanthines (author's transl)].
Habersang S; Leuschner F; Stroman F; Domenico A; Schlichtegroll A
Arzneimittelforschung; 1977; 27(12):22-35. PubMed ID: 15572
[TBL] [Abstract][Full Text] [Related]
5. [A multi-centre study of reproterol, a bronchodilator (author's transl)].
Nolte D; Galgóczy G; Lode H; Mándi A; Matthys H; Stresemann E
Dtsch Med Wochenschr; 1977 Apr; 102(16):619-23. PubMed ID: 856569
[TBL] [Abstract][Full Text] [Related]
6. Influence of reproterol on ciliary beat frequency of human bronchial epithelium in vitro.
Hesse H; Kasparek R; Mizera W; Unterholzner C; Konietzko N
Arzneimittelforschung; 1981; 31(4):716-8. PubMed ID: 7195718
[TBL] [Abstract][Full Text] [Related]
7. [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)].
Bonaduce D; Ferrara N; Canonico V; Cocozza M; Petretta M; Romano E; Rengo F
G Ital Cardiol; 1981; 11(10):1467-71. PubMed ID: 7341317
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
[TBL] [Abstract][Full Text] [Related]
9. [Isolation and structure determination of metabolites of xantinol from rat urine (author's transl)].
Tauscher M; Eckhardt G; Geisel B; Credner K
Arzneimittelforschung; 1976; 26(7):1342-4. PubMed ID: 1036921
[TBL] [Abstract][Full Text] [Related]
10. [On the bronchodilatory effect of reproterol (author's transl)].
Mándi A; Galfóczy G; Galambos E
Arzneimittelforschung; 1977; 27(12):60-3. PubMed ID: 322677
[TBL] [Abstract][Full Text] [Related]
11. Application of inexpensive equipment for HPLC to assays for reproterol in pharmaceutical tablets.
Elli F; Testa R; Dolfini E
Boll Chim Farm; 1980 Nov; 119(11):653-8. PubMed ID: 7225226
[No Abstract] [Full Text] [Related]
12. [Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
Citone C; Carelli M; Di Marcotullio G; Tubaro M; Milazzotto F
Clin Ter; 1984 Sep; 110(5):429-36. PubMed ID: 6149836
[No Abstract] [Full Text] [Related]
13. Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma.
Juergens UR; Stöber M; Vetter H
Respiration; 1999; 66(3):220-4. PubMed ID: 10364737
[TBL] [Abstract][Full Text] [Related]
14. Excretion study of the beta2-agonist reproterol in human urine.
Georgakopoulos CG; Tsitsimpikou C; Spyridaki MH
J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):141-8. PubMed ID: 10348180
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of the partial beta-agonist doxaminol in dog.
Neidlein R; Volland C; Strein K
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):130-6. PubMed ID: 1970733
[TBL] [Abstract][Full Text] [Related]
16. Screening of beta-2 agonists and confirmation of fenoterol, orciprenaline, reproterol and terbutaline with gas chromatography-mass spectrometry as tetrahydroisoquinoline derivatives.
Henze MK; Opfermann G; Spahn-Langguth H; Schänzer W
J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):93-105. PubMed ID: 11232861
[TBL] [Abstract][Full Text] [Related]
17. [The bronchdilating action of reproterol in patients with bronchial asthma and chronic obstructive bronchitis (author's transl)].
Tabori D; Conkic B; Todic V; Mijatovic M; Mirkovc S; Zecević D; Camprag D
Arzneimittelforschung; 1977; 27(12):55-60. PubMed ID: 576833
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of methacholine-induced bronchoconstriction with reproterol, a new beta agonist-xanthine derivative.
Klaustermeyer WB; Kuhn GJ; Santiago SM; Wehiky I; Hunt EJ
Ann Allergy; 1981 Apr; 46(4):189-92. PubMed ID: 7011112
[TBL] [Abstract][Full Text] [Related]
19. [Toxicological investigation of reproterol (author's transl)].
Habersang S; Leuschner F; von Schlichtegroll A
Arzneimittelforschung; 1977; 27(12):45-52. PubMed ID: 576831
[TBL] [Abstract][Full Text] [Related]
20. [Postoperative respiratory therapy: bronchospasmolytic activity and side-effects of some recently introduced beta-sympatheticomimetic agents (author's transl)].
Brandl M; Beer S; Hamer P
Anasth Intensivther Notfallmed; 1981 Aug; 16(4):197-202. PubMed ID: 7027819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
